论文部分内容阅读
目的探讨复方丹参注射液在≤5岁儿童哮喘轻中度发作期的治疗效果。方法62例哮喘轻中度发作期患儿随机分为治疗组31例和对照组31例,对照组予抗炎、平喘西药基础治疗;治疗组在对照组治疗基础上予复方丹参注射液0.5ml/(kg·d)静点,5d后统计疗效。结果治疗组总有效率93.55%;治疗组在改善临床症状、体征方面明显优于对照组,差异有统计意义(P<0.05)。结论复方丹参注射液治疗≤5岁儿童轻中度哮喘发作效果满意。
Objective To investigate the therapeutic effect of compound Danshen injection on mild to moderate asthma in children ≤5 years of age. Methods Sixty-two children with mild-to-moderate asthma attack were randomly divided into treatment group (n = 31) and control group (n = 31). The control group was treated with anti-inflammatory and antiasthmatic western medicine. The treatment group was given Fufang Danshen Injection 0.5 ml / (kg · d) point, 5d after the statistical effect. Results The total effective rate of the treatment group was 93.55%. The treatment group was better than the control group in improving clinical symptoms and signs, the difference was statistically significant (P <0.05). Conclusion Salvia miltiorrhiza injection is effective in treating mild-moderate asthma in children ≤5 years old.